Skip to main content

Advertisement

Table 1 Baseline characteristics of included patients in the in vivo study, Dabola

From: Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

Characteristics   AS/AQ (n = 110) AS/SP (n = 110) p
Gender ratio M/F 54/56
0.96
51/59
0.86
0.16
Age (months) Mean (SD) 29.5 (14.9) 28.7 (12.9) 0.68
Middle-upper arm circumference (mm) Mean (SD) 149.2 (12.5) 147.6 (10.8) 0.29
Axillary temperature (°C) Median (IQR) 39.0 (37.8–39.8) 39.1 (38.1–40.0) 0.46
Haemoglobin (g/dL) Mean (SD) 8.7 (2.0) 8.7 (1.9) 0.92
Asexual parasitaemia (/μL) Geometric mean (IQR) 40,492
20,121–97,615
34,716
15,658–41,226
0.45
Gametocyte carriage n (%)
95% CI
13 (11.8)
6.4 – 19.3
11 (10.0)
5.1 – 17.8
0.66
  1. SD: Standard deviation IQR: Inter-Quartile Range